Improving the Quality of Life for Patients Through Technologically Enhanced Formulations
Adare Pharma Solutions’ experienced staff of 60 formulation development experts provide our customers with drug formulation solutions for even the most complex dosage form challenges.
We leverage our deep knowledge, innovative technologies, and unparalleled experience to the development of stable, effective drug delivery platforms that allow our customers’ projects to achieve the optimum dosage form needed for faster commercialization.
Capabilities
- Formulation development of Solid Dose Tablets
- Capsules
- Liquids
- Solutions
- Pediatric Formulation
- Product Design
- Formulation Optimization
- Sourcing of APIs & Excipients
- Analytical Method Development & Validation
- Prototype Development
- Small-Scale Non-GMP & GMP Development Capabilities
Expertise
- Pre-formulation
- QBD Principles applied with formulation development
- Support including physical characterization
- Pediatric Formulation
- Analytical method development & validation
- IMPD manufacture and QP release
- Technology transfer
- ICH stability programs at all conditions
- Small scale non-GMP and GMP development capability
Speak With An Expert
Nathan Dormer
Director, Drug Product Development
Nathan Dormer, Ph.D., is the Director of Drug Product Development at Adare Pharma Solutions and is responsible for pharmaceutical development activities at Adare’s Lenexa, KS and Philadelphia, PA facilities, where he supports a team of formulation scientists and analysts. He is a pharmaceutical scientist and bioengineer by training, with more than 16 years of experience developing microsphere-based solid oral and parenteral/implantable dosage forms in academic, innovator, and CDMO settings. Dr. Dormer earned his B.S. in Chemical Engineering and his Ph.D. (w/Honors) in Bioengineering from The University of Kansas while receiving NIH-sponsored Pharmaceutical Biotech Training.